Older adults in the United States who were diagnosed with new-onset epilepsy were frequently prescribed older, outdated antiepileptic drugs (AEDs), and about half experienced delays in treatment beyond 30 days, according to an analysis of a large, racially diverse database of US Medicare beneficiaries published in the February 7 online edition of Epilepsia.
